SANUWAVE Health (SNWV) Stock: Buy, Sell, or Hold?
SNWV - SANUWAVE Health, Inc. Common Stock
$4.10
0.10 (2.50%)
▲
5d:
-7.87%
30d:
-23.65%
90d:
-72.09%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 14, 2026
0d
Get Alerted When SNWV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: SNWV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: SNWV shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$12.96
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.05
49.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SNWV is currently trading at $4.10, which is considered oversold relative to its 30-day fair value range of $4.30 to $5.49. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.1) compared to its historical average (26.3). Remarkably, the market is currently pricing in an annual earnings decline of 25.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SNWV is in a strong downtrend. Immediate support is located at $3.92, while resistance sits at $4.84.
Market Sentiment: SNWV scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $40.00 (+875.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, SNWV is in a strong downtrend. Immediate support is located at $3.92, while resistance sits at $4.84.
Market Sentiment: SNWV scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $40.00 (+875.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$4.30 -
$5.49
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 875.6% below Wall St target ($40.00)
- WARNING: Composite score 39/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$4.30 -
$5.49
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.92
Resistance Level
$4.84
Current Trend
Strong Downtrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.08
Wall Street Target
$40.00
(+875.6%)
Revenue Growth (YoY)
-3.1%
Earnings Growth (YoY)
-99.6%
Profit Margin
34.7%
Valuation Discount vs History
-25.0% cheaper
PE vs Historical
11.1 vs 26.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-25.0%
(market-implied from PE analysis)
1-Year Target
$3.69
(-10%)
2-Year Target
$3.32
(-19%)
3-Year Target
$2.99
(-27%)
3-Yr Target (if PE normalizes)
(PE: 11→26)
$7.09
(+73%)
📈
Valuation based on Current Earnings
Trailing PE: 5.00 | Current EPS (TTM): $0.80
Bull Case
$2.20
(-46%)
Analyst growth -50.0%, PE expands to 5.5
Base Case
$2.00
(-51%)
Market implied -50.0%, PE stable at 5.0
Bear Case
$2.72
(-34%)
Severe decline -20.0%, PE contracts to 4.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.1 to 26.3
Stabilization Target:
$9.73
(+137.3%)
PE Expansion Potential:
+137.3%
Share & Embed Analysis
Last updated: September 12, 2026 10:54 AM ET
Data refreshes hourly during market hours. Next update: 11:54 AM
Data refreshes hourly during market hours. Next update: 11:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SNWV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
